Lixia Qiao

机构：World Wide Web Consortium, China Medical University

发表论文 19 篇 · 总被引 296 次 · h-index 4

代表论文

• Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial (2023 · The Lancet · 被引 147)
• Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial (2025 · Nature Medicine · 被引 49)
• Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials (2025 · The Lancet · 被引 42)
• Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension (2024 · JAMA Cardiology · 被引 35)
• Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes (2025 · JAMA Network Open · 被引 4)
• Adipose‑derived mesenchymal stem cell‑derived HCAR1 regulates immune response in the attenuation of sepsis (2022 · Molecular Medicine Reports · 被引 4)